Atlas Trials

Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects

Clinical trial NCT02765724 · COMPLETED

Trial details

NCT number
NCT02765724
Sponsor
CTI BioPharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelofibrosis
Start date
2015-01-01
Primary completion
2015-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.